Join us for our Lunch Symposium at VIVA 2026
Sirolimus Coated Balloon for PAD Treatment: Where Evidence Meets Experience
Lunch Symposium
Where Evidence Meets Experience
International experts review randomised and real-world evidence on sirolimus coated balloons in PAD, from the femoropopliteal segment to below-the-knee, with practical insights for everyday practice.
Agenda
- 1Introduction & Session Objectives
- 2How effective is Sirolimus Coated Balloon for the treatment of PAD: 2-year results from SIRONA and Update from the LIMES RCTDierk Scheinert
- 3What we have learned from the randomized SirPAD (Sirolimus-coated balloon for PAD) trialStefano Barco
- 4Sirolimus-coated balloons for femoropopliteal lesions: Practical considerationsTim Wittig
- 5The future of BTK: what has and hasn't worked?Sahil Parikh
- 6Discussion and Conclusion
Chairperson
Moderator
Panellists
Concept Medical at VIVA 2026
Where to Find Us in Las Vegas
A lunch symposium and new SirPAD late-breaking data on Monday 5 October, and our team at Booth 203 throughout the conference.
Late-Breaking
Patients in the new SirPAD femoropopliteal subgroup analysis, presented by Stefano Barco.
Booth
Exhibit & Market, Bellagio Las Vegas.
Meetings
Book time with our clinical and commercial team during the conference.
Featured Technology
Sirolimus Coated Balloon for Peripheral Intervention
MagicTouch PTASirolimus coated PTA balloon catheter
MagicTouch PTA is Concept Medical's sirolimus coated balloon for peripheral artery disease, built on Nanolute™ carrier technology. It is the device studied in SIRONA, LIMES and the academic SirPAD trial, all discussed at VIVA 2026.
- Mon · 8:25 AMSirPAD femoropopliteal subgroup — Late-Breaking Clinical Trial
- Mon · 12:00 PMLunch Symposium — Where Evidence Meets Experience
- Mon · 3:55 PMThe SirPAD Study — Late-Breaking Deep Dive
Clinical & Scientific Evidence
The Evidence Discussed at VIVA 2026
Randomised and real-world data on MagicTouch PTA, presented by the investigators themselves.
SirPAD Femoropopliteal Subgroup
A new analysis of 597 patients treated for femoropopliteal disease without tissue loss, a population in whom revascularisation aims for durable symptom relief as well as limb preservation. Presented by Stefano Barco (Co-PI).
SirPAD Trial
An academic, investigator-initiated RCT of 1,252 patients with symptomatic infrainguinal PAD. The primary results, published in the New England Journal of Medicine, showed a significant reduction in major adverse limb events with MagicTouch angioplasty at one year.
SIRONA & LIMES
Two-year results from the SIRONA trial and an update from the LIMES randomised controlled trial, presented by Dierk Scheinert.
Schedule
Concept Medical Sessions at VIVA 2026
All times local (PDT).
Monday, 5 October 2026
Full programme: viva-foundation.org/agenda
Meet the Experts
Symposium Presenters
Dierk Scheinert
Germany · Moderator
Stefano Barco
Switzerland · SirPAD Co-PI
Tim Wittig
Germany
Sahil Parikh
USA · Chairperson
About the Conference
What Is VIVA 2026?
Vascular InterVentional Advances (VIVA), now in its 24th year, is a leading multidisciplinary forum for peripheral vascular disease, organised by the not-for-profit VIVA Foundation.
VIVA brings together specialists in vascular surgery, interventional cardiology, interventional radiology, vascular medicine, neurointervention, neurosurgery and cardiothoracic surgery for live cases, hands-on workshops, expert debate and late-breaking clinical trial results. It runs alongside The VEINS, the Foundation's dedicated venous meeting, with 26 clinical trials presented across the two conferences in 2026.
VIVA 2026 · 3–6 October · Booth 203
Let's Connect at VIVA 2026
Join our lunch symposium on Monday 5 October in the Red Theatre, and visit the Concept Medical team at Booth 203.